AN AGE-STRUCTURED MODEL WITH IMMUNE RESPONSE OF HIV INFECTION
暂无分享,去创建一个
[1] A two-strain hiv-1 mathematical model to assess the effects of chemotherapy on disease parameters. , 2005, Mathematical biosciences and engineering : MBE.
[2] M. L. Chambers. The Mathematical Theory of Optimal Processes , 1965 .
[3] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[4] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[5] S. Nagata,et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. , 1999, The Journal of clinical investigation.
[6] B. Adams,et al. Dynamic multidrug therapies for hiv: optimal and sti control approaches. , 2004, Mathematical biosciences and engineering : MBE.
[7] Alan S Perelson,et al. HIV-1 infection and low steady state viral loads , 2002, Bulletin of mathematical biology.
[8] D. Kirschner,et al. Optimal control of the chemotherapy of HIV , 1997, Journal of mathematical biology.
[9] J. C. López-Marcos,et al. Runge-Katta methods for age-structured popualtion models , 1995 .
[10] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[11] Angela R. McLean,et al. Zidovudine and HIV: Mathematical models of within‐host population dynamics , 1995 .
[12] Guanrong Chen,et al. Feedback control of a biodynamical model of HIV-1 , 2001, IEEE Transactions on Biomedical Engineering.
[13] J. Corbeil,et al. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy , 1994, Journal of virology.
[14] D. Kirschner,et al. Predicting differential responses to structured treatment interruptions during HAART , 2004, Bulletin of mathematical biology.
[15] Philip Laird,et al. Dynamic Optimization , 1992, ML.
[16] Denise Kirschner,et al. A model for treatment strategy in the chemotherapy of AIDS , 1996 .
[17] Helen Moore,et al. A mathematical model for treatment-resistant mutations of hiv. , 2005, Mathematical biosciences and engineering : MBE.
[18] M A Nowak,et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] Veerle Fack,et al. A parallel iterated correction algorithm for the numerical solution of Volterra equations , 1995 .
[20] Max Gunzburger,et al. Perspectives in flow control and optimization , 1987 .
[21] S. Lenhart,et al. OPTIMIZING CHEMOTHERAPY IN AN HIV MODEL , 1998 .
[22] José Álvarez-Ramírez,et al. Feedback Control of the chemotherapy of HIV , 2000, Int. J. Bifurc. Chaos.
[23] Alan S. Perelson,et al. Mathematical Analysis of Age-Structured HIV-1 Dynamics with Combination Antiretroviral Therapy , 2007, SIAM J. Appl. Math..
[24] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[25] G. F. Webb,et al. Understanding drug resistance for monotherapy treatment of HIV infection , 1997, Bulletin of mathematical biology.
[26] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[27] Jeehyun Lee,et al. Optimal control of an age-structured model of HIV infection , 2012, Appl. Math. Comput..
[28] Daniel Coombs,et al. An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells. , 2004, Mathematical biosciences and engineering : MBE.
[29] Carlos Castillo-Chavez,et al. How May Infection-Age-Dependent Infectivity Affect the Dynamics of HIV/AIDS? , 1993, SIAM J. Appl. Math..
[30] Chung Choo Chung,et al. Optimal Scheduling of Drug Treatment for HIV Infection : Continuous Dose Control and Receding Horizon Control , 2003 .
[31] S. Ruan,et al. A delay-differential equation model of HIV infection of CD4(+) T-cells. , 2000, Mathematical biosciences.
[32] G. Webb. Theory of Nonlinear Age-Dependent Population Dynamics , 1985 .
[33] A. Trkola,et al. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. , 1999, The Journal of clinical investigation.
[34] B. Adams,et al. HIV dynamics: Modeling, data analysis, and optimal treatment protocols , 2005 .
[35] J. Lisziewicz,et al. Control of HIV despite the discontinuation of antiretroviral therapy. , 1999, The New England journal of medicine.
[36] Carlos Castillo-Chavez,et al. Diseases with chronic stage in a population with varying size. , 2003, Mathematical biosciences.
[37] W. Fleming,et al. Deterministic and Stochastic Optimal Control , 1975 .
[38] Harvey Thomas Banks,et al. A state‐dependent Riccati equation‐based estimator approach for HIV feedback control , 2006 .
[39] L. S. Pontryagin,et al. Mathematical Theory of Optimal Processes , 1962 .
[40] Z. Feng,et al. A Two-Strain Tuberculosis Model with Age of Infection , 2002, SIAM J. Appl. Math..
[41] Jeehyun Lee,et al. Free Terminal Time Optimal Control Problem of an HIV Model Based on a Conjugate Gradient Method , 2011, Bulletin of mathematical biology.
[42] Harvey Thomas Banks,et al. Feedback control of HIV antiviral therapy with long measurement time , 2011 .